Thyroid nodules: which tests follow the ultrasound and in what order

Step one: TSH — function before form

The first test for any nodule is TSH: it shows how the gland works as a whole. A suppressed TSH speaks of possible nodule autonomy — then free T4 and free T3 are added and scintigraphy is discussed. A normal or elevated TSH moves the route to the other branch: assessing nodule structure by ultrasound and, when criteria are met, fine-needle biopsy.

The principle is simple: hormones do not answer 'is the nodule malignant', they answer 'how is the gland working'. These two tasks — function and structure — are solved in parallel and by different methods.

Step two: antibodies by situation

TPO antibodies are added when the ultrasound picture or TSH hints at autoimmune inflammation: thyroiditis changes both the look of the gland and the monitoring tactics. Thyroglobulin antibodies are not needed in routine nodule assessment — their place is where thyroglobulin itself is measured.

It is important not to swap tasks: positive antibodies do not make a nodule malignant and do not remove the question of biopsy if ultrasound criteria call for it. They describe the gland's background, not the nodule's nature.

Calcitonin: a separate test with a separate goal

Calcitonin is produced by the gland's C-cells, and its sustained rise is a marker of medullary thyroid cancer — a rare but fundamentally different tumour. In some countries calcitonin is part of standard nodule assessment; in others it is assigned for suspicious signs: a firm fast-growing nodule, family history, characteristic ultrasound findings.

The test has caveats: a moderate rise also occurs in other states — from gland inflammation to certain medications and reduced kidney function. A borderline result is therefore confirmed by repeat measurement and reviewed with an endocrinologist; very high values are informative by themselves.

Thyroglobulin: why it is not drawn here

Thyroglobulin is a protein made by any thyroid tissue: normal, nodular and tumour alike. While the gland is in place, its level cannot tell good from evil, so in primary nodule assessment it is useless. Its real niche is monitoring after total thyroid removal for differentiated cancer: there, any rise in thyroglobulin speaks of residual tissue.

In that niche thyroglobulin always goes paired with its antibodies: antibodies distort the measurement, and without accounting for them the number can be misread. Outside that situation the test is not assigned — it is a frequent unnecessary line on bills.

The laboratory minimum and its expansion for nodules

Markers covered in this article

Frequently asked questions

Sources

Keep reading